|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4365 | (2006.01) |
| A61K 31/4365 | (2013.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 13/12 | (2018.01) |
| (11) | Patento numeris | 4125887 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21715913.6 |
| Europos patento paraiškos padavimo data | 2021-04-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-02-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-02-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2021/058792 |
| Data | 2021-04-02 |
| (87) | Numeris | WO 2021/198506 |
| Data | 2021-10-07 |
| (30) | Numeris | Data | Šalis |
| 20167687 | 2020-04-02 | EP |
| (72) |
BOLZE, Sébastien , FR
FOUQUERAY, Pascale , CH
HALLAKOU-BOZEC, Sophie , FR
|
| (73) |
Poxel ,
Immeuble le Sunway
259/261 Avenue Jean Jaures, 69007 Lyon,
FR
|
| (54) | USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |
| USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) |